Huadong Medicine (000963.SZ): The registration application for lidocaine injection with cross-linked sodium hyaluronate gel has been accepted.
East China Pharmaceuticals (000963.SZ) announced that its wholly-owned subsidiary Xinkeli Mei Xue (Hangzhou) Medical Technology Co., Ltd.
Huadong Medicine (000963.SZ) announced that its wholly-owned subsidiary Xinkelimei Medical Technology (Hangzhou) Co., Ltd. has received an "Acceptance Notice" issued by the National Medical Products Administration (NMPA) for its application for registration of three types of medical devices, including Lidocaine injection cross-linked hyaluronic acid sodium gel MaiLi Precise.
Related Articles
US Stock Market Move | Obook Holdings (OWLS.US) debuts on the US stock market with an opening stock price drop of nearly 20%.
US Stock Market Move | Q3 performance exceeds expectations, JB Hunt Carriage Services Inc. (JBHT.US) surges over 18%
US Stock Market Move | Storage concept stocks continued to strengthen, Micron Technology, Inc. (MU.US) rose more than 7%.
US Stock Market Move | Obook Holdings (OWLS.US) debuts on the US stock market with an opening stock price drop of nearly 20%.
US Stock Market Move | Q3 performance exceeds expectations, JB Hunt Carriage Services Inc. (JBHT.US) surges over 18%
US Stock Market Move | Storage concept stocks continued to strengthen, Micron Technology, Inc. (MU.US) rose more than 7%.
RECOMMEND
